Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) for viral vectors, announced today the successful development of a high-resolution ion-exchange ...

Q3 2024 Earnings Call Transcript November 4, 2024 Eve Holding, Inc. beats earnings expectations. Reported EPS is $-0.12016, expectations were $-0.14. Operator: Good day and welcome to the Eve Air ...

PulseSight plans to submit a phase I clinical trial authorization (CTA) by the end the year, to be closely followed by a phase II proof-of-concept to demonstrate the efficacy and the safety of its ...

Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall acceptable safety profile observed so far and initial ...

Xometry offers a significant growth runway and a well-defined path to non-GAAP profitability and free cash flow generation.

Good afternoon, everyone, and thank you for joining the Lumen Technologies third quarter 2024 earnings call. On the call to ...

HighByte®, an industrial software company, today announced the approval of a new appointee to the company's Board of Directors, Megan Buntain. She joins Ben Sampson of Standard Investments as the ...

Good morning, everyone, and welcome to the strategic announcement of Q4 and full year 2024 earnings conference call. (Operator Instructions) Please also note, today's event is being recorded. At this ...

Q4 2024 Results Conference Call November 5, 2024 8:00 AM ETCompany ParticipantsColleen Mettler - Vice President, ...